APTN · Adaptin Bio, Inc. · Analyst Estimates
$6.27
At close · Aug 19
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has evaluated the Company's operating plan against its existing cash and determined that substantial doubt exists about the Company's ability to support its operations and fund its obligations for the next twelve months from the date of issuance of these condensed consolidated financial statements.”View the 10-Q filed Aug 13, 2026
Market Cap
$57.89M
Shares
9.23M
Volume · Aug 19
200
Avg daily vol (12 sessions)
256
Analyst Estimates
Compare analyst forecasts for Adaptin Bio, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Published by the company
No verified consensus is held yet; the last collection attempt failed and will be retried.
Consensus not yet available
No verified consensus is held yet; the last collection attempt failed and will be retried.